ELEV
Elevation Oncology
ELEV
ELEV
Delisted
ELEV was delisted on the 22nd of July, 2025.
64 hedge funds and large institutions have $10.8M invested in Elevation Oncology in 2025 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 12 increasing their positions, 24 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
25% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 32
50% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 24
Holders
64
Holding in Top 10
1
Calls
$18K
Puts
–
Top Buyers
| 1 | +$529K | |
| 2 | +$527K | |
| 3 | +$523K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$346K |
| 5 |
RC
Rangeley Capital
New Canaan,
Connecticut
|
+$332K |
Top Sellers
| 1 | -$1.23M | |
| 2 | -$1.03M | |
| 3 | -$316K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$238K |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$179K |
